Privación del Sueño y Melatonina Factores que Influyen en la Enfermedad de Alzheimer: Revisión Sistemática
Milexa Carolina Villa Rodas, Jennifer Cleotilde Armijos Maldonado, Ángel José Chú Lee. Ciencia Latina Revista Científica Multidisciplinar, 2025-10-23
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
La enfermedad de Alzheimer (EA) es la demencia neurodgenerativa más prevalente a nivel mundial, en los últimos años se ha resaltado su relación con los trastornos del sueño y la desregulación de la melatonina. El objetivo de esta revisión fue analizar la influencia del déficit de sueño y la alteración de los niveles de melatonina en la fisiopatología, progresión y su posible abordaje terapéutico en la enfermedad de Alzheimer. Se realizó una revisión sistemática (PRISMA 2020) de literatura publicada entre 2020 y 2025 en PubMed, ScienceDirect, Scielo y Google Scholar, aplicando criterios PICOS. De 1.559 registros, se incluyeron 24 estudios. Los hallazgos muestran que la mala calidad del sueño, la fragmentación circadiana y los trastornos respiratorios del sueño aumentan el riesgo de EA, acumulación de β-amiloides y proteínas tau, así como una peor evolución clínica, especialmente en mujeres y portadores del alelo APOE ε4. La evidencia preclínica respalda que la melatonina ejerce efectos neuroprotectores multimodales, con mayor beneficio en fases tempranas. Se concluye que el sueño constituye un factor modificable relevante en la EA, mientras que la melatonina emerge como biomarcador y posible coadyuvante terapéutico. Se requieren ensayos clínicos que definan causalidad, dosis y ventanas óptimas de intervención.
What this study adds
Evidence grade: Low
This systematic review found that poor sleep quality, circadian fragmentation, and sleep breathing disorders are associated with increased Alzheimer's risk and worse clinical course, especially in women and APOE ε4 carriers. It reports that preclinical evidence supports melatonin's neuroprotective effects, with greater benefit in early stages, but states that clinical trials are needed to define causality, dose, and optimal intervention windows.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Rodas, M. C. V., Maldonado, J. C. A., & Lee, Á. J. C. (2025). Privación del Sueño y Melatonina Factores que Influyen en la Enfermedad de Alzheimer: Revisión Sistemática. Ciencia Latina Revista Científica Multidisciplinar. https://doi.org/10.37811/cl_rcm.v9i5.20119
Vancouver
Rodas MCV, Maldonado JCA, Lee ÁJC. Privación del Sueño y Melatonina Factores que Influyen en la Enfermedad de Alzheimer: Revisión Sistemática. Ciencia Latina Revista Científica Multidisciplinar. 2025. doi:10.37811/cl_rcm.v9i5.20119.
BibTeX
@article{rodas2025-fcc8b6d3,
author = {Rodas, Milexa Carolina Villa and Maldonado, Jennifer Cleotilde Armijos and Lee, Ángel José Chú},
title = {{Privación del Sueño y Melatonina Factores que Influyen en la Enfermedad de Alzheimer: Revisión Sistemática}},
journal = {Ciencia Latina Revista Científica Multidisciplinar},
year = {2025},
doi = {10.37811/cl_rcm.v9i5.20119},
url = {https://doi.org/10.37811/cl_rcm.v9i5.20119}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- De 1.559 registros, se incluyeron 24 estudios.
- Los hallazgos muestran que la mala calidad del sueño, la fragmentación circadiana y los trastornos respiratorios del sueño aumentan el riesgo de EA, acumulación de β-amiloides y proteínas tau, así como una peor evolución clínica, especialmente en mujeres y portadores del alelo APOE ε4.
- La evidencia preclínica respalda que la melatonina ejerce efectos neuroprotectores multimodales, con mayor beneficio en fases tempranas.
- Se concluye que el sueño constituye un factor modificable relevante en la EA, mientras que la melatonina emerge como biomarcador y posible coadyuvante terapéutico.
- Se requieren ensayos clínicos que definan causalidad, dosis y ventanas óptimas de intervención.
Why it matters
This systematic review found that poor sleep quality, circadian fragmentation, and sleep breathing disorders are associated with increased Alzheimer's risk and worse clinical course, especially in women and APOE ε4 carriers. It reports that preclinical evidence supports melatonin's neuroprotective effects, with greater benefit in early stages, but states that clinical trials are needed to define causality, dose, and optimal intervention windows.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Evidence strengthLow
How this study scored 26/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 25 of the 96 points we could judge it on, which is 26 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Ciencia Latina Revista Científica Multidisciplinar) |
| Journal's citation record | 0 / 4 | Ciencia Latina Revista Científica Multidisciplinar: journal h-index 36 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Ángel José Chú Lee holds only 7 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 0 / 3 | Universidad Tecnica de Machala: institution h-index 54 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Points | 25 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 25 of the 96 points we could judge it on is 26 out of 100. |
| Total | 26 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.37811/cl_rcm.v9i5.20119
- Original source →
- Free full text: Ciencia Latina Revista Científica Multidisciplinar →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Genetics from nearby years
Also in Genetics
198 studies in the library are filed under Genetics with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Genetics hub.